Article
Changes to management influenced by next-generation sequencing of pancreatic duct aspirates among patients with main pancreatic duct dilatation of unclear etiology: a multicenter cohort study.
Gastrointestinal endoscopy - 1 Jul 2026
Jones Alex R, Kannan Amudhan, Ley Dana, Ramirez Oscar Ramirez, Sheth Megha, Murimwa Gilbert, Abbas Ali, Deverakonda Abhi, Bishop Christofer, Coleman Veronica, Foley Blake, Ellis Daniel, Gopal Deepak, Benson Mark, Stadmeyer Peter, Khatri Gaurav, Zafar Syed Nabeel, Polanco Patricio M, Zeh Herbert, Mansour John, Fleming Jason, Singhi Aatur, Minter Rebecca, Kubiliun Nisa, Pfau Patrick, Sawas Tarek
Abstract excerpt
BACKGROUND AND AIMS: Main pancreatic duct (MPD) dilatation of unclear etiology presents a diagnostic challenge because the management of neoplastic and non-neoplastic causes differs significantly. We aimed to assess the clinical utility of next-generation sequencing (NGS) in the management of MPD dilatation. METHODS: We retrospectively identified patients with dilated MPD (≥6 mm) of unclear etiology who underwent...
Topics
Join the communities discussing this publication.